3 Beta-and Gammacoronavirus, respectively (Pratelli, 2011) . Deltacoronavirus is a new genus 68 proposed in July 2013 (ictvonline.org/virustaxonomy) (Table 1) . 69
Lipid rafts are special plasma membrane microdomains with an increased structural order, 70 designated liquid ordered domains in model membranes. Lipid rafts, enriched in sphingolipids, 71 cholesterol and associated proteins, play a critical role in different biological aspects of the life 72 cycle of several viruses and are involved in many processes of viruses infection. In particular, the 73 tight packaging of the sphingolipids is maintained by the presence of cholesterol, a major 74 constituent of the lipid rafts, and several proteins partition into these membrane domains (Imhoff et 75 al., 2007) . Extraction of cholesterol destroys this order, leading both to the disorganization of the 76 lipid rafts microdomains and to the dissociation of proteins bound to the lipid rafts (Barman & 77 Nayak, 2007) . 78
The role of cholesterol in the entry of nonenveloped viruses was demonstrated for Simian 79
Virus 40 (SV40), rotavirus, rhinovirus and enterovirus (Anderson et al., 1996; Suzuki & Suzuki, 80 2006) . Successful virus entry of enveloped viruses requires the binding to specific cellular receptors 81 and the fusion of the viral membrane with the cellular membrane. Accumulating evidences suggest 82 that enveloped virus entry may require cholesterol in either of the two membranes involved, or in 83 both. Human Immunodeficiency Virus (HIV) type-1 infection requires cholesterol both in the target 84 cell membrane and in the viral envelope (Guyader et al., 2002; Liao et al., 2001 Liao et al., , 2003 . Cholesterol 85 in both membranes is also required for Bovine Herpesvirus 1 (BoHV-1) infection of MDBK cells 86 (Zhu et al., 2010) . For other viruses in the Alphaherpesvirinae subfamily of the Herpesviridae, such 87 as Herpes Simplex Virus 1 (HSV-1), Varicella-Zoster Virus (VZV) and Porcine Pseudorabies Virus 88 (PRV), cell membrane cholesterol is required during virus entry (Bender et al., 2003; Hambleton et 89 al., 2007; Desplanques et al., 2008) . Other viruses are sensitive to cholesterol depletion from the 90 cellular membrane, such as Semliki Forest Virus (SFV), Murine Leukemia Virus (MLV), Ebola 91 Virus (EBOV) and Marburg Virus Disease (MVD) (Ahn et al., 2002; Bavari et al., 2002; Lu et al., 92 2002; Phalen & Kielian, 1991) . For influenza virus and Duck Hepatitis B Virus (DHBV) the 93 presence of cholesterol in its viral envelope is critical, but it is not essential in the target cell (Sun & 94 Whittaker, 2003; Funk et al., 2008) , and recently it has been demonstrated that Canine Distemper 95 Virus (CDV) also requires cholesterol in the viral envelope (Imhoff et al., 2007) . In contrast, in the 96 case of Vesicular Stomatitis Virus (VSV), replication is not affected by cholesterol depletion, and 97 numerous strains of the Flaviviridae family, i.e. Dengue Virus (DENV) and Yellow Fever Virus 98 (YFV), enter and infect cells independent of cholesterol (Umashankar et al., 2008) . 99
It is known that coronaviruses differ in their tissue tropism and different cellular receptors 100 are involved in virus entry. The depletion of cellular and viral cholesterol inhibits virus entry of 101 4 several coronaviruses: Mouse Hepatitis Virus (MHV) (Choi et al., 2005) , Severe Acute Respiratory 102 Syndrome (SARS)-CoV (Li et al., 2007) , HCoV-229E (Nomura et al., 2004) , TGEV (Ren et al., 103 2008) and avian Infectious Bronchitis Virus (IBV) (Imhoff et al., 2007) . In the present study we 104 investigated to our knowledge the role of cholesterol in the viral envelope and in the cellular 105 membrane for CCoV infection of A72 cells. The methyl-β-cyclodextrin (MβCD), a cholesterol-106 binding agent, was employed to remove cholesterol and to disrupt the lipid rafts. 107 108 RESULTS 109
Infection efficiency after cholesterol depletion from cellular membrane 110
To investigate if cellular cholesterol was essential for CCoV entry into susceptible cells, 111 A72 monolayers were mock pretreated or pretreated with various concentrations of MβCD and 112 subsequently infected with CCoV strain SE/97. Cells were cultured and virus yield was determined 113 with virus titration assay. MβCD treatment of A72 cells resulted in an abatement of the virus 114 production in a dose-dependent manner, suggesting that cell membrane cholesterol is necessary at 115 the virus entry stage for CCoV infection. At a concentration of 15 mM, the reduction of the 116 infection rate was about 68% (Fig. 1a) . 117
To confirm that the inhibitory effects for CCoV replication at the virus entry stage were due 118 to cholesterol depletion, cell membrane cholesterol was replenished with different concentrations of 119 exogenous cholesterol and the recovery of virus infection was analyzed. Cholesterol-depleted cells 120 (pretreated with 15 mM MβCD) were incubated with exogenous cholesterol, infected with CCoV 121 and virus yield was investigated with virus titration assay. As shown in Fig. 1b the inhibitory effect 122 was reversed with cholesterol replenishment and virus production was partially restored to values 123 close to those observed prior to MβCD treatment. At a concentration of 700 μg ml -1 , infectivity was 124 restored to an average of 77% compared to the mock treated cells. 125
The concentration of MβCD and cholesterol employed in this study did not cause significant 126 adverse effect on cell viability (data not shown). 127
Infection efficiency after cholesterol depletion from viral membrane 128
To analyze whether cholesterol in the viral envelope is required for CCoV entry in 129 susceptible cells, the virus was mock treated or treated with different concentrations of MβCD 130 prior to infection. Cell monolayers were incubated with non-treated and MβCD-treated viral 131 suspensions and virus yield was determined with virus titration assay. As reported in Fig. 2a , the 132 exposure of CCoV to MβCD resulted in a dose-dependent inhibitory effect on the virus infectivity. 133
In particular at a concentration of 9 mM MβCD, virus yield was reduced by about 73%. 134 5 To verify whether the effect of cholesterol depletion was reversible, exogenous cholesterol 135 at various concentrations was added virus suspension pretreated with 9 mM MβCD. Cholesterol 136 replenishment resulted in an increase of the infectivity of CCoV and at concentration of 700 μg ml -1 137 infectivity reached about 82% of the value observed prior to cholesterol depletion ( Fig. 2b) . membranes during infection and can thus play a role through their preferential partitioning into the 166 membrane microdomains. Specifically, viral entry brings together virions and host cells that will 167 6 interact in a subtle-controlled step-by-step process: each step therefore relies on a paired 168 combination of lipids and proteins (Blaising & Pécheur, 2013) . 169
Viruses have evolved complex relationship with their host cells and many viruses modulate 170 lipid composition, lipid synthesis and signaling of their host cell (Blasing & Pécheur, 2013) . In 171 particular, lipids are essential for the life cycle of several coronaviruses. The depletion of cellular 172 cholesterol inhibits virus entry of MHV (Thorp & Gallagher, 2004; Choi et al., 2005) , SARS-CoV 173 (Li et al., 2007; Glende et al., 2008) , HCoV-229E (Nomura et al., 2004) and IBV (Thorp & 174 Gallagher, 2004; Nomura et al., 2004; Li et al., 2007; Imhoff et al., 2007) . Ren et al. (2008) showed 175 the importance of cholesterol in both the cellular and viral membranes for TGEV infection and in 176 addition a functional analysis suggested that cholesterol depletion affects a post-adsorption step in 177 TGEV entry process (Yin et al., 2010) . Therefore, the importance of cholesterol-rich microdomains 178 appears to be a general feature of the entry mechanism of different viruses and, as far as 179 coronaviruses are concerned, the purpose of this study was to analyze the contribution of lipids in 180 the infectivity of CCoV, and in particular whether cholesterol was important as a constituent of the 181 virus, of the host cells or of both. CCoV lifecycle appears to be closely connected to plasma 182 membrane cholesterol. In the case of TGEV and HCoV-229E, the cholesterol dependence is 183 consistent with the presence of porcine and human aminopeptidase N, respectively (Ren et al., 184 2008) . Conversely, MHV and SARS-CoV use different receptors, MHVR and ACE2, respectively, 185 which are nonraft-proteins (Thorp & Gallagher, 2004; Warner et al., 2005) .Our analysis did not 186 provide evidence that the activities of the S protein, binding to sialic acids and to aminopeptidase N, 187
were reduced in cholesterol-depleted virions. However, optimal infectivity of CCoV requires 188 cholesterol in plasma membrane. In particular, cholesterol depletion resulted in a reduction but not 189 in the abolishment of virus infectivity and virus entry may occur also at lower cholesterol levels but 190 increased cholesterol makes this process more efficient. At a concentration of 700 μg ml -1 , 191 infectivity was restored to an average of 77% compared to the mock treated cells, confirming that 192 the reduction was due to the cholesterol depletion, and that the inhibitory effects was partially 193
reversible. 194
Interestingly, our study also demonstrated the role of cholesterol in the viral membrane. This 195 datum is particularly important because coronaviruses mature by a budding process at the early 196 compartments of the secretory pathway (Tooze et al., 1984) , where the content of cholesterol and 197 sphingolipids is lower compared to the plasma membrane (Sevlever et al., 1999) . As 
Cell and virus 219
The A72 canine fibroma cell line, established from a tumour surgically removed from a 220 female 8-year-old Golden Retriever dog (Binn et al., 1980) , was employed. The cells were 221 maintained in Dulbecco Minimal Essential Medium (DMEM) supplemented with 5% foetal calf 222 serum (FCS) and passaged twice a week. CCoV strain SE/97 ("SE" stands for "Seeing Eye Dogs", 223
Pennsylvania isolate) was employed throughout the study. The virus, gently supplied from Prof. 224 L.E. Carmichael (Cornell Vet, Ithaca -New York), was isolated on A72 cells from an adult dogs 225 with mild enteritis and recovered within a week. SE/97 was propagated on A72 cells and grown in 226 serum-free medium. The viral titre was determined in 96-well microtitration plates with A72 cells 227 and was expressed as TCID 50 50μl -1 calculated using the Reed-Muench formula (Reed & Muench, 228 1938) . CCoV-induced cytophatic effect of infected cells was determined based on the appearance of 229 enlarged, bizarrely shaped cells followed by focal cell detachment. The infectivity titre of the stock 230 virus was 10 5.5 TCID 50 50µl -1 . 231
Reagents 232
The methyl-β-cyclodextrin (MβCD) (C4555, Sigma-Aldrich) is a strictly surface-acting drug that 233 can selectively and rapidly remove cholesterol from the plasma membrane in preference to other 234 membrane lipids (Barman & Nayak, 2007) . This cholesterol depletion reagent has been widely 235 employed in studying the effect of both cholesterol depletion and lipid raft disassembly, and current 236 data indicate that it inhibits virus entry of several viruses (Choi et al., 2005; Li et al., 2007; Nomura 237 et al., 2004; Imhoff et al., 2007; Ren et al., 2008) . To remove the plasma membrane cholesterol, 238 concentrations of 3, 6, 9, 10, 12, 15 mM of MβCD in DMEM were prepared. 239 Water soluble cholesterol (C4951, Sigma Aldrich) was employed to replenish cholesterol 240 after extraction of cellular and viral cholesterol using MβCD. 241
Cholesterol depletion and replenishment from cellular membrane at the virus-entry stage 242
To remove cholesterol from cellular membrane, cells monolayers seeded in 24-well plates, 243 containing approximately 300.000 A72 cells/per well, were washed three times with DMEM and 244 incubated for 30 min at 37°C in a CO 2 incubator with serum-free DMEM in the absence (mock 245 cells) or in the presence (treated cells) of MβCD at the concentrations of 3, 6, 9, 10, 12, 15 mM. To 246 determine if cellular cholesterol depletion at the virus-entry stage affects virus replication, MβCD-247 treated or mock cells were washed three time with DMEM to remove MβCD and incubated with 248 100 TCID 50 50µl -1 of virus suspension at 37°C for 1 h. Fresh DMEM was then applied and the cells 249
were incubated for 48 h in a CO 2 incubator. For investigation of the infection efficiency, MβCD-250 treated or mock cells were frozen e thawed three time and subjected to virus titration in A72 cells as 251 described above. 252
For cholesterol replenishment, monolayers of A72 cells in 24-well plates, containing 253 approximately 300.000 A72 cells/per well, were mock pretreated or pretreated with 15 mM MβCD 254 for 30 min at 37°C to remove cellular membrane cholesterol as described above. The concentrations 255 of 15 mM was selected because in the cholesterol depletion test, it was the optimal MβCD 256 concentration not producing collateral effects for A72 cells. 257
The cells were then washed three times with DMEM, replenished with different concentrations of 258 water-soluble cholesterol in DMEM ranging from 400 to 800 μg ml -1 and incubated for 1 h at 37°C. 259
Mock cells were replenished with serum-free medium. For cell infection analysis after cellular 260 cholesterol replenishment, the cells were washed three times with DMEM, and viral suspensions 261 containing 100 TCID 50 50µl -1 were applied to the cell monolayers. The plates were incubated for 1 262 h at 37°C (Zhu et al., 2010) , fresh DMEM was applied and the cells were incubated for 48 h in a 263 CO 2 incubator. For investigation of the infection efficiency, treated or mock cells were frozen e 264 thawed three time and subjected to virus titration in A72 cells as described above. 265
The reduction and the restoration of viral infectivity were converted to percentages for an 266 immediate understanding of the reduced and restored amounts, respectively. 267
All the experiments were repeated twice under the same conditions. 268
Cholesterol depletion from viral membrane and effect on virus infectivity 269 9
For viral cholesterol extraction, 1 ml of viral suspensions containing 100 TCID 50 50µl -1 were 270 incubated with MβCD at the concentrations of 3, 6, 9, 10, 12, mM, respectively for 1 h at 37°C. To 271 determine if the virus cholesterol was essential for CCoV infectivity, after cholesterol depletion 272 from viral membrane, cell monolayers were washed three times with DMEM and then incubated 273 with MβCD-treated viral suspensions at 37°C for 1 h. To avoid negative effects of MβCD on A72 274 cells, the inoculums was diluted 1:3 in DMEM before infection. The controls were mock treated. 275
Finally, treated cells and controls were washed three times with DMEM and incubated for 48 h in a 276 CO 2 incubator. To analyze the infection efficiency after viral cholesterol depletion, the monolayers 277 were frozen e thawed three time and subjected to virus titration in A72 cells as described above. 278
For cholesterol replenishment, 1 ml of CCoV suspensions were mock treated or treated with 9 mM 279 MβCD for 30 min at 37°C, then replenished with different concentrations of water-soluble 280 cholesterol in DMEM ranging from 400 to 800 μg ml -1 and incubated for 1 h at 37°C. The 281 concentrations of 9 mM was selected because in the cholesterol depletion test, it was the optimal 282
MβCD concentration not producing collateral effects for CCoV. Mock cells were replenished with 283 serum-free medium. For cell infection analysis after viral cholesterol replenishment, the cells were 284 washed three times with DMEM, and cholesterol-replenished or non-replenished (control) viral 285 suspensions were applied to the cell monolayers and incubated at 37°C for 48 h (Ren et al., 2008) . 286
For investigation of the infection efficiency, samples were frozen e thawed three time and subjected 287 to virus titration in A72 cells as described above. 288
The reduction and the restoration of viral infectivity were converted to percentages for an 289 immediate understanding of the reduced and restored amounts, respectively. 290
All the experiments were repeated twice under the same conditions. 291
Cellular and viral cholesterol content measurement 292
Cellular and viral cholesterol were measured using the Amplex® Red Cholesterol Assay Kit 293 (A12216, Invitrogen/Life Technologies) according to manufactured instructions and according to 294 protocols reported by Ren et al. (2008) . 295
To determine cellular cholesterol, confluent monolayer of A72 cells grown on six-well plate 296 were treated with different concentrations of MβCD ranging from 3 to 15 mM. At the same time, 297 monolayers of A72 cells in six-well plate pretreated with 15 mM of MβCD, were replenished with 298 various concentrations of exogenous cholesterol ranging from 400 to 800 μg ml -1 . All the 299 monolayers were then washed three times with DMEM, trypsinised with EDTA, centrifuged at 800 300
x g at 4°C for 5 min to remove cellular debris and the pellets were suspended in PBS. The cellular 301 cholesterol concentration was determined in triplicase with the Amplex® Red Cholesterol Assay 302
Kit. Non-treated A72 cells were used as control. 303 10 To determine viral cholesterol, 1 ml of two different viral suspensions (10 5.5 TCID 50 μl -1 304 each) were treated in parallel with MβCD for cholesterol depletion, specifically one suspension 305 with different concentrations of the drug from 3 to 12 mM and the other with 9 mM. Both 306 suspensions were then treated with exogenous water-soluble cholesterol by applying final 307 concentrations ranging from 400 to 800 μg ml -1 . The suspensions were centrifuged at 800 x g at 4°C 308
for 5 min to remove cellular debris and then ultracentrifuged at 140.000 rpm for 1 h at +4°C. The 309 pellets were suspended in PBS and subjected to cholesterol concentration determination in triplicase 310 with the Amplex® Red Cholesterol Assay Kit. Non-treated virus was employed as control. 311
All the experiments were repeated twice under the same conditions. 312
It should be noted that CCoV was grown in serum-free medium to avoid that cholesterol 313 measurement was affected by serum cholesterol. 314 315 316
Figures legend 495

Fig. 1 496
CCoV infection efficiency after cholesterol depletion and replenishment from cellular membrane. a) 497
MβCD treatment of A72 cells reduced infectivity of CCoV in a dose-dependent manner and at a 498 concentration of 15 mM, viral titre suffered a reduction of about 68%. b) Cholesterol-depleted cells 499 were replenished with exogenous cholesterol and virus production was partially restored. 500
The 100% infectivity value corresponds to the original titre of the stock virus. 501
Fig. 2 502
CCoV infection efficiency after cholesterol depletion and replenishment from viral membrane. a) 503
MβCD treatment of CCoV reduced infectivity in a dose-dependent manner and at a concentration of 504 9 mM, viral titre suffered a reduction of about 73%. b) Replenishment of cholesterol in the viral 505 membrane resulted in an increase of CCoV infectivity. 506
The 100% infectivity value corresponds to the original titre of the stock virus. 507 
